4+ hour, 40+ min ago  (84+ words) | Its prototype being used by 10, 000+ scientists | Inshorts Inshorts Stanford unveils AI agent that automates complex biomedical research Stanford researchers have unveiled Biomni, a general-purpose AI agent that automates complex biomedical research workflows. With a single prompt, it can carry out…...

13+ hour, 23+ min ago  (934+ words) A groundbreaking study by a team of researchers from Tel Aviv University's Gray Faculty of Medical and Health Sciences offers hope to millions of people suffering from irreversible hearing loss. The researchers identified a unique biological mechanism that could, in…...

1+ day, 1+ hour ago  (289+ words) The oncology space today is an array of different innovative mechanisms of action, and companies of all sizes are trying to keep pace with the cutting edge of the space. For Debiopharm, one of those novel areas is DNA damage…...

1+ day, 12+ hour ago  (354+ words) Apertura has entered a cooperative research and development agreement (CRADA) with various NIH institutes for a gene therapy to treat Niemann-Pick Disease Type C1 (NPC1). The company signed the agreement to test the investigational therapy with Eunice Kennedy Shriver National Institute of…...

1+ day, 9+ hour ago  (585+ words) Reg Med Net is part of Taylor & Francis Group. Original story from the University of Rochester Medicine (URochester Medicine; NY, USA). Researchers have developed a gene therapy platform using the brain's glymphatic system to deliver therapeutic genes to glial cells…...

1+ day, 10+ hour ago  (274+ words) University of Rochester Medicine researchers have developed a gene therapy platform designed to deliver therapeutic genes broadly through the brain while targeting glial cells. The approach uses the brain's glymphatic transport system and engineered viral vectors, a combination researchers say…...

1+ day, 11+ hour ago  (186+ words) Confluence Genetics announced the launch of Cas-CLEAR, short for Collaterally Enhanced Activated Ribonuclease, a CRISPR-based platform built to treat cancers carrying defined genetic signatures. The company's lead programs target hepatocellular carcinoma (HCC), a leading cause of cancer death worldwide with…...

1+ day, 12+ hour ago  (99+ words) Life Sciences IP Review - Explaining genetically engineered rodents to a jury'and ultimately beating Amgen Harbour's trial counsel shares the strategy behind the company's $20m win, revealing how a highly technical patent dispute became a case about credibility as much as science....

1+ day, 9+ hour ago  (81+ words) Nature Reviews Molecular Cell Biology (2026) Cite this article Where a cell resides can be as important as what genes it expresses. Spatial context influences gene expression, cell states and cell'cell communications. Although pooled CRISPR screening combined with single-cell sequencing enables…...

1+ day, 12+ hour ago  (457+ words) Roche has discontinued two Huntington's disease programmes after its Ionis-partnered drug tominersen failed to improve patients' symptoms and a separate candidate raised concerns in animal studies. Why it matters: The decisions eliminate two of Roche's three clinical approaches to lowering…...